Quality in Innovation, Quality of Life. The community, support, access to capital, world-class talent, and relentless optimism for the future make Charlottesville an ideal place to start and scale a biotechnology company.
An In-Depth Digital Series
These are the stories of a thriving biotech hub, united in a founding spirit of collaboration and entrepreneurship.
These are the inspiring people and the breakthrough ideas that make us a diverse and innovative BioHub.
Thomas Thorpe, CEO, Afton Scientific
At Afton Scientific, Tom leads a team of nearly 70 employees manufacturing small batches of sterile injectable drugs that might not otherwise make it to patients. Tom shares his insights on creating a bio manufacturing company in Charlottesville.
Indoor Biotechnologies advances research on allergic diseases and asthma to offer patients allergen tests to reduce risk to exposure. Martin shares more about the growth of his company as one of the original biotech companies in Charlottesville, and offers insights into the broader community growth as co-founder of CvilleBioHub.
ZielBio is developing technology to discover cancer’s Achille’s Heel. Founder Kim Kelly’s steadfast vision for the company and commitment to advancing innovation has led to ZielBio’s first-in-human clinical trial of their proprietary antibody ZB131. Kim shares insights on developing new targeted therapies, raising capital and the company’s mission to help cancer patients live longer, healthier lives.
Brian Wamhoff, Head of Innovation and COO, HemoShear Therapeutics
HemoShear Therapeutics is providing novel approaches to treat rare disorders as a growing drug discovery company in Charlottesville. From significant non-dilutive grants early on to a recent record Series A for the region, the company has achieved impressive funding milestones and is moving forward to the clinic. Brian shares more about the company’s mission and why Charlottesville is a great place to call home.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.